Summary
Cognizant Technology Solutions Corporation (CTSH) reported strong financial performance for the nine months ended September 30, 2014, demonstrating robust revenue and net income growth. Revenues increased by 15.9% to $7.52 billion compared to the same period in 2013. Net income saw a significant rise of 19.0% to $1.08 billion, with diluted earnings per share growing to $1.76 from $1.48. The company's growth was driven by strong performance across all its business segments, particularly Financial Services and Healthcare, and continued penetration in key geographic markets like North America and Europe. The company also highlighted its strategic client growth and increasing demand for its broader service offerings, including consulting, IT Infrastructure services, and Business Process Services. The acquisition of TriZetto for $2.7 billion was announced in September 2014, expected to close in Q4 2014, indicating a strategic move to bolster its healthcare IT capabilities. Despite overall positive results, operating margins saw a slight decrease, attributed to increased compensation and benefit costs and investments in business growth, partially offset by favorable currency movements and lower hedging losses. The company continues to focus on investing in talent, expanding service offerings, and opportunistic acquisitions to maintain its competitive edge in the dynamic IT services market.
Financial Highlights
46 data points| Revenue | $2.58B |
| SG&A Expenses | $506.00M |
| Operating Income | $457.50M |
| Interest Expense | $300K |
| Net Income | $355.60M |
| EPS (Basic) | $0.58 |
| EPS (Diluted) | $0.58 |
| Shares Outstanding (Basic) | 608.10M |
| Shares Outstanding (Diluted) | 612.10M |
Key Highlights
- 1Revenue for the nine months ended September 30, 2014, increased by 15.9% to $7.52 billion compared to the prior year period.
- 2Net income for the same period rose by 19.0% to $1.08 billion, with diluted EPS increasing to $1.76.
- 3The company announced a definitive agreement to acquire TZ US Parent, Inc. (TriZetto) for $2.7 billion, a significant strategic move expected to close in Q4 2014.
- 4Strong revenue growth was observed across all reportable segments, with Financial Services and Healthcare showing notable increases.
- 5North America remains the largest market, contributing 76.4% of revenue for the nine months ended September 30, 2014, with significant growth also seen in Europe.
- 6Operating margin slightly decreased year-over-year due to increased compensation costs and strategic investments, despite revenue growth.
- 7The company maintained a strong liquidity position with $4.62 billion in cash, cash equivalents, and short-term investments as of September 30, 2014.